Nomograms for Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection

被引:220
|
作者
Yang, Hwai-I
Sherman, Morris
Su, Jun
Chen, Pei-Jer
Liaw, Yun-Fan
Iloeje, Uchenna H.
Chen, Chien-Jen [1 ]
机构
[1] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan
关键词
LIVER FIBROSIS; BIOCHEMICAL MARKERS; HEART-DISEASE; PREDICTION; CIRRHOSIS; SCORE; PREVENTION; GENOTYPE; MODELS; LEVEL;
D O I
10.1200/JCO.2009.27.4456
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Counseling patients with chronic hepatitis B virus (HBV) on their individual risk of liver disease progression is challenging. This study aimed to develop nomograms for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B. Patients and Methods Two thirds of the Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer Hepatitis B Virus (REVEAL-HBV) study cohort was allocated for model derivation (n = 2,435), and the remaining third was allocated for model validation (n = 1,218). Previously confirmed independent risk predictors included in three Cox proportional hazards regression models were sex, age, family history of hepatocellular carcinoma, alcohol consumption habit, serum ALT level, hepatitis B envelope antigen (HBeAg) serostatus, serum HBV DNA level, and HBV genotype. Regression coefficients were rounded into integer risk scores, and predicted risk over 5- and 10-year periods for each risk score was calculated and depicted in nomograms. The predictive accuracy was evaluated using the area under the receiver operating characteristic curve (AUROC) and the correlation between predicted and observed hepatocellular carcinoma risk. Results All selected risk predictors were statistically significant in all models. In each model, either HBeAg seropositivity or HBeAg seronegativity with high viral load (HBV DNA level >= 100,000 copies/mL) and genotype C infection had the highest risk scores. All AUROCs for risk prediction nomogram were >= 0.82 in both model derivation and validation sets. The correlation coefficients between the observed hepatocellular carcinoma risk and the nomogram-predicted risk were greater than 0.90 in all model derivation and validation sets. Conclusion These easy-to-use nomograms based on noninvasive clinical characteristics can accurately predict the risk of hepatocellular carcinoma in patients with chronic hepatitis B. They may facilitate risk communication between patients and clinicians.
引用
收藏
页码:2437 / 2444
页数:8
相关论文
共 50 条
  • [1] Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection
    Ito, Kenichi
    Arai, Makoto
    Imazeki, Fumio
    Yonemitsu, Yutaka
    Bekku, Dan
    Kanda, Tatsuo
    Fujiwara, Keiichi
    Fukai, Kenichi
    Sato, Kenichi
    Itoga, Sakae
    Nomura, Fumio
    Yokosuka, Osamu
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (02) : 243 - 249
  • [2] Prevention of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection
    Kim, Beom Kyung
    Han, Kwang-Hyub
    Ahn, Sang Hoon
    ONCOLOGY, 2011, 81 : 41 - 49
  • [3] Hepatitis B virus infection and the risk of hepatocellular carcinoma
    Tan, Ya-Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (44) : 4853 - 4857
  • [4] Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma
    Kew, M. C.
    PATHOLOGIE BIOLOGIE, 2010, 58 (04): : 273 - 277
  • [5] Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection
    Chayanupatkul, Maneerat
    Omino, Ronald
    Mittal, Sahil
    Kramer, Jennifer R.
    Richardson, Peter
    Thrift, Aaron P.
    El-Serag, Hashem B.
    Kanwal, Fasiha
    JOURNAL OF HEPATOLOGY, 2017, 66 (02) : 355 - 362
  • [6] Diabetes Mellitus is a Risk Factor for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection in China
    Li, Xu
    Xu, Hongqin
    Gao, Pujun
    MEDICAL SCIENCE MONITOR, 2018, 24 : 6729 - 6734
  • [7] External validation of hepatocellular carcinoma risk scores in patients with chronic hepatitis B virus infection in China
    Lou, Tao
    Li, Bin
    Xiong, Pian
    Jin, Caiting
    Chen, Yagang
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (10) : 1373 - 1380
  • [8] Prevalence of occult hepatitis B virus infection and Torque teno virus infection and their association with hepatocellular carcinoma in chronic hepatitis C patients
    Rosa, Agatha S.
    Araujo, Oscar C.
    Savassi-Ribas, Flavia
    Fernandes, Carlos A.
    Coelho, Henrique S.
    Niel, Christian
    Villela-Nogueira, Cristiane A.
    Araujo, Natalia M.
    VIRUS RESEARCH, 2017, 242 : 166 - 172
  • [9] Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis
    Li, Xiaofei
    Sheng, Lina
    Liu, Liwen
    Hu, Yongtao
    Chen, Yongxin
    Lou, Lianqing
    BMC GASTROENTEROLOGY, 2020, 20 (01)
  • [10] Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection
    Hann, Hie-Won
    Wan, Shaogui
    Lai, Yinzhi
    Hann, Richard S.
    Myers, Ronald E.
    Patel, Fenil
    Zhang, Kejin
    Ye, Zhong
    Wang, Chun
    Yang, Hushan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (01) : 131 - 138